BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15781230)

  • 1. Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells.
    Stanley G; Harvey K; Slivova V; Jiang J; Sliva D
    Biochem Biophys Res Commun; 2005 Apr; 330(1):46-52. PubMed ID: 15781230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3.
    Jiang J; Slivova V; Valachovicova T; Harvey K; Sliva D
    Int J Oncol; 2004 May; 24(5):1093-9. PubMed ID: 15067330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganoderma lucidum (Reishi) in cancer treatment.
    Sliva D
    Integr Cancer Ther; 2003 Dec; 2(4):358-64. PubMed ID: 14713328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J; Slivova V; Sliva D
    Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling.
    Jiang J; Slivova V; Harvey K; Valachovicova T; Sliva D
    Nutr Cancer; 2004; 49(2):209-16. PubMed ID: 15489214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicinal mushroom cuts off prostate cancer cells' blood supply.
    Johnston N
    Drug Discov Today; 2005 Dec; 10(23-24):1584. PubMed ID: 16376814
    [No Abstract]   [Full Text] [Related]  

  • 7. Androgen receptor-dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells.
    Zaidman BZ; Wasser SP; Nevo E; Mahajna J
    Int J Oncol; 2007 Oct; 31(4):959-67. PubMed ID: 17786330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
    Guo Y; Wang S; Hoot DR; Clinton SK
    J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin induces cell migration and the expression of growth factors in human prostate cancer cells.
    Frankenberry KA; Somasundar P; McFadden DW; Vona-Davis LC
    Am J Surg; 2004 Nov; 188(5):560-5. PubMed ID: 15546570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF).
    Ling MT; Lau TC; Zhou C; Chua CW; Kwok WK; Wang Q; Wang X; Wong YC
    Carcinogenesis; 2005 Oct; 26(10):1668-76. PubMed ID: 15905202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effect of green tea and Ganoderma lucidum on invasive behavior of breast cancer cells.
    Thyagarajan A; Zhu J; Sliva D
    Int J Oncol; 2007 Apr; 30(4):963-9. PubMed ID: 17332936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
    Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells.
    Sliva D; Sedlak M; Slivova V; Valachovicova T; Lloyd FP; Ho NW
    J Altern Complement Med; 2003 Aug; 9(4):491-7. PubMed ID: 14499024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Src kinase activity by Ad-mda7 suppresses vascular endothelial growth factor expression in prostate carcinoma cells.
    Inoue S; Branch CD; Gallick GE; Chada S; Ramesh R
    Mol Ther; 2005 Oct; 12(4):707-15. PubMed ID: 16054437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of proliferation and oxidative stress by extracts of Ganoderma lucidum in the ovarian cancer cell line OVCAR-3.
    Hsieh TC; Wu JM
    Int J Mol Med; 2011 Dec; 28(6):1065-9. PubMed ID: 21887458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor production in human prostate cancer cells is stimulated by overexpression of platelet 12-lipoxygenase.
    McCabe NP; Selman SH; Jankun J
    Prostate; 2006 May; 66(7):779-87. PubMed ID: 16482570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo.
    Xiao D; Singh SV
    Cancer Res; 2007 Mar; 67(5):2239-46. PubMed ID: 17332354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of angiogenesis by vitamin D-binding protein: characterization of anti-endothelial activity of DBP-maf.
    Kalkunte S; Brard L; Granai CO; Swamy N
    Angiogenesis; 2005; 8(4):349-60. PubMed ID: 16400520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway.
    Wang X; Klein RD
    Mol Carcinog; 2007 Nov; 46(11):912-23. PubMed ID: 17427962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.